Related Experiment Video
Updated: May 17, 2025
Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
Published on: December 4, 2010
Chronic rejection models for vascularized composite tissue allotransplantation
Daniel T Fisher1, Emily Mackey2, Eugene Kononov1
1Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Abstract:
Vascularized composite tissue allotransplantation (VCA) has transformed patients' lives by enabling limb, face, abdominal wall, and penile transplants. Despite advancements in screening and immunosuppression, chronic rejection continues to limit the success of VCA. Lack of reliable preclinical models exacerbates this challenge. Here, we report on new mouse models of chronic rejection following heterotopic hind limb VCA. We employed different levels of MHC mismatch using CD8 knockout C57BL/6 mice as recipients along with BALB/c or B6 H2-Ab1bm12 mice as donors. Transient CD4 T cell depletion was induced to allow graft maturation. Evaluation included gross findings, changes in immune status changes, production of donor-specific antibodies (DSA), C4d levels, and histopathological alterations. Two chronic rejection models displayed common features of clinical chronic graft rejection, such as skin stricture, hair loss, adnexal atrophy, extensive fibrosis and mast cell infiltration without widespread necrotic changes common in acute rejection. Similar to chronic rejection patients, large populations of activated B and plasma cells were detected in the recipient's immune system as well as increased DSA and C4d production. Collectively, our models closely replicate the immunological and histopathological aspects of chronic graft rejection post-VCA, and could provide a new platform for evaluation of novel therapeutic interventions prior to clinical evaluation.
Insights
New mouse models mimic chronic graft rejection after vascularized composite tissue allotransplantation (VCA). These models show key features of chronic rejection, aiding the development of new therapies for VCA patients.
Area of Science:
- Transplantation immunology
- Preclinical research models
Background:
- Vascularized composite tissue allotransplantation (VCA) offers life-changing reconstructive options, but chronic rejection remains a significant barrier to long-term success.
- Current preclinical models inadequately replicate the complexities of chronic rejection, hindering the development of effective treatments.
Purpose of the Study:
- To develop and characterize novel mouse models that accurately mimic chronic rejection following hind limb VCA.
- To provide a platform for evaluating new therapeutic strategies for chronic graft rejection.
Main Methods:
- Heterotopic hind limb VCA in CD8 knockout mice using varying MHC mismatches (BALB/c or B6 H2-Ab1bm12 donors).
- Transient CD4 T cell depletion to facilitate graft maturation.
- Comprehensive evaluation including gross pathology, immune status, donor-specific antibodies (DSA), C4d deposition, and histopathology.
Main Results:
- Two models successfully replicated key features of clinical chronic graft rejection, including skin changes, fibrosis, and mast cell infiltration, without acute necrotic changes.
- Recipients exhibited increased donor-specific antibodies (DSA) and C4d deposition, mirroring findings in human chronic rejection.
- Expansion of activated B and plasma cells was observed in the recipient immune system.
Conclusions:
- The developed mouse models closely recapitulate the immunological and histopathological hallmarks of chronic rejection after VCA.
- These models offer a valuable preclinical platform for testing novel therapeutic interventions before clinical application in VCA patients.
More Related Videos
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:40Cell-mediated Immune Responses